EyePoint's Duravyu meets primary endpoint in Phase 2 DME trial, showing potential to compete with Regeneron's Eylea and Roche ...

GSK said it is holding steady in the face of ongoing regulatory and potential political pressures on its vaccines franchise, ...

Amgen's obesity drug AMG-513 on clinical hold; company reaffirms obesity market ambitions while advancing MariTide program ...

Novo Nordisk reports 26% sales growth in 2024, but projects lower 2025 growth of 16-24%. Full-year Wegovy sales up 86%, ...

Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs ...

Johnson & Johnson has asked a federal district court to expedite its decision in a case over the company’s proposed 340B ...

China tensions, following US restrictions on Chinese rivals BGI and MGI. Illumina says China accounts for 7% of Q3 revenue.

Astellas is reorganizing its management team, and while it doesn't involve a change at the top as Daiichi Sankyo announced ...

At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.

Omega Therapeutics anticipates filing for bankruptcy within the next week, the epigenomic medicines company said in a filing.

Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her great-grandmother, has struck her relatives with the first signs of memory ...

Bicycle Health, a telehealth provider for opioid use disorder treatment led by Ankit Gupta, turns profitable and raises ...